Gene therapy approaches to ventricular tachyarrhythmias
Abstract Ventricular tachycardia arising from a healed myocardial infarction scar continues to be a significant cause of morbidity and mortality. Drug therapy has been inadequate to meet this challenge, and implantable devices are limited by expense and technical problems. We have proposed the use o...
Saved in:
Published in | Journal of electrocardiology Vol. 40; no. 6; pp. S187 - S191 |
---|---|
Main Authors | , , |
Format | Journal Article |
Language | English |
Published |
United States
Elsevier Inc
01.11.2007
Elsevier Science Ltd |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Abstract Ventricular tachycardia arising from a healed myocardial infarction scar continues to be a significant cause of morbidity and mortality. Drug therapy has been inadequate to meet this challenge, and implantable devices are limited by expense and technical problems. We have proposed the use of gene therapy for cardiac arrhythmias. In this review, we present a model of postinfarct ventricular tachycardia, a method for gene delivery to this area, and results of KCNH2 -G628S gene transfer to manipulate cellular refractory properties in the arrhythmia model. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 corresponding author email: kdonahue@metrohealth.org current address: Johns Hopkins University School of Medicine Ross 844 720 N. Rutland Ave. Baltimore, MD 21205 |
ISSN: | 0022-0736 1532-8430 |
DOI: | 10.1016/j.jelectrocard.2007.05.036 |